Mobile Investor

 Stock Information
IMUC (NYSE)
Last Price: 3.08
Last Trade: 4:00 PM ET - Mar 29, 2017
Change: 0.22 down  (6.67%)
Open: 3.49
Close: 3.30
High: 3.50
Low: 2.90
52-Week High: 13.60
52-Week Low: 1.83
Volume: N/A
Stock price graph
 Recent News
Mar 23, 2017
ImmunoCellular Therapeutics and Memgen Announce Letter of Intent for Potential Joint Immuno-Oncology Collaboration
Mar 14, 2017
ImmunoCellular Therapeutics Receives Audit Opinion With Going Concern Explanation
Mar 9, 2017
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Mar 6, 2017
ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2016 Financial Results on March 9, 2017
Mar 6, 2017
ImmunoCellular Therapeutics Provides Update on ICT-107 Phase 3 Glioblastoma Trial and Announces Advances in Stem-to-T-Cell Research Program
 Events & Presentations
Mar 9, 2017 - 2:00 PM PT
ImmunoCellular Therapeutics Fourth Quarter 2016 Financial Results
 Financial Filings
Mar 9, 2017
Form 10-K - IMMUNOCELLULAR THERAPEUTICS, LTD.
Nov 10, 2016
Form 10-Q - IMMUNOCELLULAR THERAPEUTICS, LTD.
Oct 4, 2016
Form DEFA14A - IMMUNOCELLULAR THERAPEUTICS, LTD.
Oct 4, 2016
Form DEF 14A - IMMUNOCELLULAR THERAPEUTICS, LTD.
Sep 23, 2016
Form PRE 14A - IMMUNOCELLULAR THERAPEUTICS, LTD.
Aug 22, 2016
Form 10-Q - IMMUNOCELLULAR THERAPEUTICS, LTD.
This is an optimized Investor Page for viewing on your mobile devices. To view our entire Investor Relations site, click here.
© 2017 ImmunoCellular